Breaking News Instant updates and real-time market news.

RGRX

RegeneRx

$0.00

(0.00%)

09:38
09/30/19
09/30
09:38
09/30/19
09:38

RegeneRx: Phase 3 ARISE-3 trial 'progressing smoothly' according to plan

RegeneRx Biopharmaceuticals announced that GtreeBNT, its Korean partner in the U.S. development of RGN-259 for the treatment of dry eye disease, issued an update on the U.S. phase 3 clinical trial. The following translation was provided to RegeneRx by GtreeBNT, with certain clarifications made by RegeneRx: "The ongoing clinical trial of dry eye -- ARISE-3 -- is progressing smoothly according to the plan. In the second and third quarters of 2019, we made significant effort to select appropriate clinical study sites, and we have identified and selected around 15 eye hospitals as study sites and started clinical trials sequentially. In addition, by actively utilizing databases held by hospitals to select patients that meet the criteria for recruiting clinicians, and by proactively asking questions to better identify patient status learned from ARISE-1 and ARISE-2, we are becoming more efficient and accurate with patient screening in this ARISE-3 clinical trial. In addition, since we are focusing more fully on clinical management based on know-how that we have learned from the two previous clinical trials, we expect that we will be able to control the risk of clinical trial failure. Furthermore, in the FDA approval process for new dry eye products, we believe that all data from previous trials as well as this ongoing study will be analyzed and included in the Data Totality concept. When you combine the results of two already completed clinical studies and the data from the currently ongoing ARISE-3 clinical trial, it is expected that all three Phase 3 studies will show the same consistent effect and trend. We also expect the pace of patient recruitment will be accelerated in the fall and winter, when the dry eye season comes, so we believe it will be easier to achieve our goal of completing the treatment of patients by the end of 2nd quarter of 2020. In the future, we will be able to talk more often about our ARISE-3 situations in order to address the interests of shareholders and related parties."

TODAY'S FREE FLY STORIES

MCS

Marcus

$33.11

(0.00%)

09:41
11/18/19
11/18
09:41
11/18/19
09:41
Conference/Events
Marcus management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

UNH

UnitedHealth

$269.44

(0.00%)

, TSM

TSMC

$53.29

(0.00%)

09:40
11/18/19
11/18
09:40
11/18/19
09:40
Options
Unusually active option classes on open November 18th »

Unusual total active…

UNH

UnitedHealth

$269.44

(0.00%)

TSM

TSMC

$53.29

(0.00%)

WDAY

Workday

$165.93

(0.00%)

MO

Altria Group

$47.97

(0.00%)

AMRN

Amarin

$23.99

(0.00%)

BSX

Boston Scientific

$42.30

(0.00%)

LK

Luckin Coffee

$27.06

(0.00%)

PTON

Peloton

$27.28

(0.00%)

GM

General Motors

$36.87

(0.00%)

TGT

Target

$113.18

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 03

    Dec

  • 09

    Dec

  • 28

    Dec

  • 30

    Jan

LOV

Spark Networks

$5.59

(0.00%)

09:39
11/18/19
11/18
09:39
11/18/19
09:39
Conference/Events
Spark Networks management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TMUS

T-Mobile

$78.05

1.18 (1.54%)

09:38
11/18/19
11/18
09:38
11/18/19
09:38
Hot Stocks
T-Mobile CEO Legere reiterates 'board appointment extends beyond transition' »

T-Mobile CEO Legere said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

LOCO

El Pollo Loco

$14.60

0.05 (0.34%)

09:37
11/18/19
11/18
09:37
11/18/19
09:37
Conference/Events
El Pollo Loco management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LOV

Spark Networks

$5.59

(0.00%)

, CRTO

Criteo

$16.57

-0.38 (-2.24%)

09:37
11/18/19
11/18
09:37
11/18/19
09:37
Hot Stocks
Spark Networks appoints Eric Eichmann as CEO »

Spark Networks SE (LOV)…

LOV

Spark Networks

$5.59

(0.00%)

CRTO

Criteo

$16.57

-0.38 (-2.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 09

    Dec

LK

Luckin Coffee

$27.06

5.53 (25.69%)

09:36
11/18/19
11/18
09:36
11/18/19
09:36
Conference/Events
Luckin Coffee management to meet with KeyBanc »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

TMUS

T-Mobile

$78.05

1.18 (1.54%)

, VZ

Verizon

$59.51

0.19 (0.32%)

09:35
11/18/19
11/18
09:35
11/18/19
09:35
Hot Stocks
T-Mobile CEO says 'only restrictions on him are working for companies I hate' »

After being asked if…

TMUS

T-Mobile

$78.05

1.18 (1.54%)

VZ

Verizon

$59.51

0.19 (0.32%)

T

AT&T

$39.49

0.53 (1.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 29

    Jan

  • 30

    Jan

ARWR

Arrowhead

$47.43

-1.08 (-2.23%)

09:33
11/18/19
11/18
09:33
11/18/19
09:33
Hot Stocks
Arrowhead presents new clinical data on candidates ARO-APOC3 and ARO-ANG3 »

Arrowhead Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

VRAY

ViewRay

$2.78

0.04 (1.46%)

09:33
11/18/19
11/18
09:33
11/18/19
09:33
Conference/Events
ViewRay participates in a conference call with Cantor Fitzgerald »

Conference call with CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

TMUS

T-Mobile

$78.05

1.18 (1.54%)

09:32
11/18/19
11/18
09:32
11/18/19
09:32
Hot Stocks
T-Mobile CEO Legere says 'plenty of qualified candidates for CFO' »

T-Mobile CEO John Legere…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

NEXA

Nexa Resources

$8.65

-0.58 (-6.28%)

09:32
11/18/19
11/18
09:32
11/18/19
09:32
Downgrade
Nexa Resources rating change  »

Nexa Resources downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$298.18

16.14 (5.72%)

, CI

Cigna

$196.08

6.41 (3.38%)

09:31
11/18/19
11/18
09:31
11/18/19
09:31
Recommendations
Anthem, Cigna, Centene, CVS Health, Humana, Molina Healthcare, Tivity Health, UnitedHealth, WellCare analyst commentary  »

Healthcare Services…

ANTM

Anthem

$298.18

16.14 (5.72%)

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

TVTY

Tivity Health

$21.31

1.26 (6.28%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 22

    Nov

  • 09

    Dec

  • 10

    Dec

  • 13

    Dec

  • 06

    Feb

BAM

Brookfield

$57.38

-0.37 (-0.64%)

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Downgrade
Brookfield rating change  »

Brookfield downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

TRIP

TripAdvisor

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Initiation
TripAdvisor initiated  »

TripAdvisor initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 25

    Nov

  • 26

    Nov

EXPE

Expedia

$95.38

0.14 (0.15%)

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Initiation
Expedia initiated  »

Expedia initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Dec

  • 09

    Dec

BKNG

Booking Holdings

$1,846.71

-17.12 (-0.92%)

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Initiation
Booking Holdings initiated  »

Booking Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LINC

Lincoln Educational

$1.70

(0.00%)

09:30
11/18/19
11/18
09:30
11/18/19
09:30
Conference/Events
Lincoln Educational management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

TMUS

T-Mobile

$78.05

1.18 (1.54%)

, WE

We Company

$0.00

(0.00%)

09:29
11/18/19
11/18
09:29
11/18/19
09:29
Hot Stocks
T-Mobile CEO Legere says 'never was in discussions with We Work' »

T-Mobile (TMUS) CEO John…

TMUS

T-Mobile

$78.05

1.18 (1.54%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 09

    Dec

ACTG

Acacia Research

$2.92

-0.07 (-2.35%)

09:29
11/18/19
11/18
09:29
11/18/19
09:29
Hot Stocks
Acacia Research to receive up to $400M in new capital from Starboard partnership »

Acacia Research announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$254.54

-0.415 (-0.16%)

09:27
11/18/19
11/18
09:27
11/18/19
09:27
Conference/Events
Lennox management to meet with KeyBanc »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SFM

Sprouts Farmers Market

$19.86

-0.04 (-0.20%)

, FIVE

Five Below

$119.60

-4.77 (-3.84%)

09:27
11/18/19
11/18
09:27
11/18/19
09:27
Hot Stocks
Sprouts Farmers Market appoints Five Below CEO Joel Anderson to board »

Sprouts Farmers Market…

SFM

Sprouts Farmers Market

$19.86

-0.04 (-0.20%)

FIVE

Five Below

$119.60

-4.77 (-3.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FC

Franklin Covey

$37.50

-0.25 (-0.66%)

09:26
11/18/19
11/18
09:26
11/18/19
09:26
Conference/Events
Franklin Covey management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

I

Intelsat

$13.40

1.27 (10.47%)

09:25
11/18/19
11/18
09:25
11/18/19
09:25
Initiation
Intelsat initiated  »

Intelsat initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CLRO

ClearOne

$1.52

-0.255 (-14.41%)

09:25
11/18/19
11/18
09:25
11/18/19
09:25
Hot Stocks
ClearOne begins shipping of CONVERGENCE AV Network Manager »

ClearOne announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.